The EIF2D Knockout HAP1 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal cell population with targeted disruption of the EIF2D gene, abrogating protein expression. This loss-of-function model facilitates investigation of EIF2D-dependent cap-independent translation initiation and its roles in cellular stress response pathways. The polyclonal editing format ensures representation of multiple disruption events, providing a robust and unbiased pool for downstream phenotypic assays.
The HAP1 cell line is a near-haploid human chronic myeloid leukemia derivative of the KBM-7 line, harboring the Philadelphia chromosome (BCR-ABL1). Its haploid genome eliminates allelic redundancy, enabling unambiguous CRISPR-mediated knockout analysis. This genetic simplicity makes HAP1 ideal for dissecting translation control mechanisms in cancer-relevant stress contexts.
EIF2D functions as an initiation factor that binds internal ribosome entry sites (IRES) on select mRNAs, enabling cap-independent ribosome recruitment under conditions such as mTORC1 inhibition, ER stress, hypoxia, or amino acid deprivation. It partners with DENR and MCTS1 to interact with the 40S ribosomal subunit and eIF3, facilitating ribosomal recycling and reinitiation. This non-canonical translation upregulates key survival proteins including the transcription factor c-MYC, anti-apoptotic XIAP and BCL-2, angiogenic VEGF, and cell cycle regulator Cyclin D1.
Within the HAP1 chronic myeloid leukemia context, EIF2D knockout ablates a critical link between stress signals and IRES-dependent synthesis of oncogenic factors. Constitutive BCR-ABL kinase activity makes this model valuable for examining cap-independent translation contributions to leukemic cell proliferation, survival, and drug resistance. The haploid state amplifies phenotypic readouts, facilitating sensitive detection of small-molecule or genetic modulators of the translation apparatus.
Applications include polysome profiling to evaluate ribosome occupancy on IRES-containing transcripts, dual-luciferase IRES reporter assays to quantify cap-independent translation, and Western blotting of targets like c-MYC following stress challenges. RNA immunoprecipitation can identify EIF2D-bound mRNAs, while puromycin incorporation assays measure global translation rates under perturbations such as amino acid starvation or mTORC1 inhibition. Integrating stress paradigms with these readouts enables drug target validation and mechanistic dissection of stress-responsive translatomes. For further technical details, please contact Ascent Research.
